Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Transplantation|October 29, 2013
Uremic toxin development in living kidney donors: a longitudinal studyMegan Rossi, Katrina L Campbell, David W Johnson, et al.
Bioinformatics and Biology Insights|February 15, 2014
Longitudinal analysis of whole blood transcriptomes to explore molecular signatures associated with acute renal allograft rejectionHeesun Shin, Oliver Günther, Zsuzsanna Hollander, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearanceDavid W Mudge, Robyn Rogers, Peter Hollett, et al.
BMC Nephrology|July 29, 2009
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)Katherine A Barraclough, Euan Noble, Diana Leary, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2006
A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patientsDavid W Johnson, Jennifer Wong, Kathryn J Wiggins, et al.
BMC Nephrology|October 4, 2011
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort studyCarolyn L van Eps, Leanne Jeffriess, Brian Haluska, et al.
Nephrology (Carlton, Vic.)|February 9, 2018
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New ZealandLucy C Fox, Solomon J Cohney, Joshua Y Kausman, et al.
Internal Medicine Journal|March 28, 2018
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New ZealandLucy C Fox, Solomon J Cohney, Joshua Y Kausman, et al.
BMC Nephrology|August 21, 2009
Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patientsJennifer K Broom, Stacey O'Shea, Sridevi Govindarajulu, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 22, 2006
Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donorsCarmel M Hawley, Jamie Kearsley, Scott B Campbell, et al.
Pageof 15